|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Yellen & Associates, Inc. |
| Information provided by: | Yellen & Associates, Inc. |
| ClinicalTrials.gov Identifier: | NCT00693953 |
Purpose
Our objective is to use neuroelectrical measures to determine the degree of processing abnormalities in individuals with Autism. The study will survey processing patterns and will locate and evaluate the degree(s) of abnormalities for further study. The abnormal results of comprehensive neuroelectrical evaluations of individuals with Autism when compared to the normative database will provide objective, verifiable, neurophysiological information with which to form novel approaches to the disorder.
| Condition |
|
Autistic Disorder Autism, Early Infantile Autism, Infantile |
| MedlinePlus related topics: | Autism |
| Study Type: | Observational |
| Study Design: | Case Control, Other |
| Official Title: | Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism |
| Estimated Enrollment: | 200 |
| Study Start Date: | June 2008 |
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
The research method will be: gathering, analyzing and utilizing data.
We will observe research subjects through neuroelectrical instrumentation, then, compare results to retrospective information collected from research subjects and a normative database.
A qualified neurologist thoroughly familiar with electrophysiology will interpret the data, and analyze it to explore the abnormalities.
The hypothesis will be evaluated.
We will, then, utilize the results to find data-based forms of treatment for those with the disorder.
Eligibility
| Ages Eligible for Study: | 5 Years to 25 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
The study population includes individuals with Autism without exclusion on the basis of sex, gender, race or ethnicity. There will be 100 research subjects, with a ratio of four males to one female, and those being approximately sixty-five children and thirty-five adults.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, California | |||||
| Yellen & Associates, Inc. | Not yet recruiting | ||||
| Northridge, California, United States, 91326 | |||||
| Contact: Dr. Andrew Yellen, PhD 818-360-3078 ext 103 docyellen@yellenandassociates.com | |||||
| Contact: Dr. Andrew Yellen, PhD 818-360-3078 ext 103 docyellen@yellenandassociates.com | |||||
| Principal Investigator: Andrew G Yellen, Phd | |||||
| Sub-Investigator: Thomas Schweller, MD | |||||
| Sub-Investigator: Tom Ward | |||||
| Yellen & Associates, Inc. |
| Principal Investigator: | Andrew G Yellen, PhD | President, Yellen & Associates, Inc. |
| Study Chair: | Thomas Schweller, MD | Neurologist |
More Information
| Responsible Party: | Yellen & Associates, Inc. ( Dr. Andrew G. Yellen ) |
| Study ID Numbers: | PA-06-278 |
| First Received: | June 5, 2008 |
| Last Updated: | June 17, 2008 |
| ClinicalTrials.gov Identifier: | NCT00693953 |
| Health Authority: | United States: Institutional Review Board |
|
|
|